How addictive are gabapentin and pregabalin? A systematic review

@article{Bonnet2017HowAA,
  title={How addictive are gabapentin and pregabalin? A systematic review},
  author={Udo Bonnet and Norbert Scherbaum},
  journal={European Neuropsychopharmacology},
  year={2017},
  volume={27},
  pages={1185-1215}
}
In the last ten years, gabapentin and pregabalin have been becoming dispensed broadly and sold on black markets, thereby, exposing millions to potential side-effects. Meanwhile, several pharmacovigilance-databases have warned for potential abuse liabilities and overdose fatalities in association with both gabapentinoids. To evaluate their addiction risk in more detail, we conducted a systematic review on PubMed/Scopus and included 106 studies. We did not find convincing evidence of a vigorous… Expand
[On the risk of dependence on gabapentinoids].
TLDR
It is thought that in patients with current or past substance use disorders, the treatment with gabapentinoids should be avoided or if indispensable, these drugs should be administered exclusively over a limited time span with caution by using a therapeutic and prescription monitoring. Expand
Should gabapentinoids be prescribed long-term for anxiety and other mental health conditions?
TLDR
It is called on NICE to re-evaluate their support for use of pregabalin in anxiety in light of its known harms, and the use of gabapentinoids off-label for other psychiatric conditions should also be re-considered. Expand
Gabapentin and Pregabalin for the Treatment of Anxiety Disorders
TLDR
This review will focus on the comparative properties of gabapentin and pregabalin, specifically the available evidence on their use in the treatment of primary anxiety disorders — GAD, social anxiety disorder, panic disorder, and obsessivecompulsive disorder. Expand
Gabapentinoid Abuse in France: Evidence on Health Consequences and New Points of Vigilance
TLDR
Addictovigilance data helped to make visible the gabapentinoid-abuse related health harms and to confirm the intrinsic abuse potential of pregabalin, which has become the first drug mentioned in forged prescriptions in 2019. Expand
Comment on “Abuse and Misuse of Pregabalin and Gabapentin: A Systematic Review Update”
TLDR
There is a glaring paucity of clinical studies about the addictive power/harms potential of GP—apart from the studies utilizing limited cohorts of people with other substance-use disorders, and into this dearth a clinical cross-over study showing that GP-dependence was quite rare in the elderly population of a German is added. Expand
Non-medical Use of Prescription Gabapentinoids (Gabapentin and Pregabalin) in Five European Countries
TLDR
The prevalence of prescription GABA analog NMU and associated demographics in five European countries with special detail of Spain was determined, finding that subjects with a history of chronic pain and lifetime substance use disorders had an increased risk of NMU of gabapentinoids. Expand
Gabapentinoid Pharmacology in the Context of Emerging Misuse Liability
TLDR
The epidemiology and pharmacology of gapapentinoids (gabapentin and pregabalin) relevant to their emerging misuse potential are reviewed to provide guidance for clinical and regulatory management and harm reduction efforts are necessary. Expand
Transient Psychosis After Low-Dose Pregabalin Discontinuation.
TLDR
A 30-year-old woman, who is single and a university graduate, admitted to the emergency department because of insomnia, pressured speech, skepticism, the idea of harm, seeing things that others did not see, and thinking that their speech was directed, is presented. Expand
Current Evidence on Abuse and Misuse of Gabapentinoids
TLDR
Some evidence supports the notion that patients with opioid use disorders may be at an increased risk of abusing gabapentinoids and that individuals with a history of psychiatric disorders or substance use disorder seem to be at high risk. Expand
Characteristics of fatal gabapentinoid-related poisoning in Australia, 2000-2020.
TLDR
The concomitant use of other drugs was close to universal, with CNS depressants predominating and mental health problems, chronic pain and substance misuse were prominent. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 181 REFERENCES
Comment: Gabapentin
TLDR
The view that the addiction risk of gabapentin is negligible in patients without a history of SUD is supported, and a larger systematic clinical trial investigating the addictive risk of GABapentin in patients with and without a relation to another Sud is warranted. Expand
Pregabalin abuse among opiate addicted patients
TLDR
The data suggest that pregabalin is liable to be abused among individuals with opiates dependency syndrome, and vigilance and caution are called for when patients with a past or current opiate dependency are exposed to treatment with preg abalin. Expand
Abuse and Misuse of Pregabalin and Gabapentin
TLDR
Evidence suggests gabapentinoids possess potential for abuse, particularly in individuals with a history of opioid abuse, and reports of such abuse are increasingly being documented, and prescribers should be aware of high-risk populations and monitor for signs of abuse. Expand
Gabapentin abuse, and delirium tremens upon gabapentin withdrawal.
TLDR
2 patients who used larger doses of gabapentin than prescribed and who then developed a withdrawal syndrome similar to delirium tremens upon discontinuation of the drug are described. Expand
[Pregabalin Dependence: A Case Report].
TLDR
Although pregabalin is a promising drug for various psychiatric disorders, it should be used carefully in patients with a history of substance dependence, as the number of case reports on the abuse potential of preGabalin has increased. Expand
Abuse of Gabapentin is Associated with Opioid Addiction
TLDR
A growing concern about gabapentin misuse was supported in this study: 26 percent of opiate addicted patients reported illegally obtaining, overusing, or malingering problems to obtain gabAPentin. Expand
[Pregabalin--a drug with abuse potential?].
TLDR
Pregabalin has been approved as an adjunct therapy for epilepsy, but also for neuropathic pain and generalized anxiety disorders and it has also been used in clinical trials to study its potential utility as a treatment for tobacco, alcohol and benzodiazepine addiction. Expand
Misuse of the γ-aminobutyric acid analogues baclofen, gabapentin and pregabalin in the UK.
TLDR
The aim of this study was to determine the prevalence, frequency and sources of misuse of the GABA analogues (baclofen, gabapentin and pregabalin) in the UK, and to benchmark against existing national data provided by the 2011/2012 Crime Survey for England and Wales. Expand
Pregabalin abuse of benzodiazepine and alcohol addicted patient.
TLDR
The case of a male patient in his late twenties with GAD and past alcohol and benzodiazepine abuse who showed similar drug-seeking behavior with PGL is reported. Expand
Gabapentin-Induced Delirium and Dependence
TLDR
The case described here involving a 38-year-old male physician with substance intoxication delirium and psychoactive substance dependence due to high self-administered doses of gabapentin suggests the need for heightened concern regarding the off-label prescription of this drug to vulnerable individuals with psychiatric conditions. Expand
...
1
2
3
4
5
...